Former President Joseph R. Biden Jr. began radiation therapy last month for an aggressive form of prostate cancer. It is unclear if his treatment has ended. By Yan Zhuang and Reid J. Epstein Former ...

Pinar Uysal-Onganer receives funding from Prostate Cancer UK. Alwyn Dart does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this ...

A noticeably frail Joe Biden was seen in public Saturday for the first time since news broke that he is undergoing radiation therapy for prostate cancer — attending evening Mass at St. Joseph on the ...

Former President Joe Biden has completed a round of radiation therapy for an aggressive form of prostate cancer. The 82-year-old finished several weeks of therapy at Penn Medicine Radiation Oncology ...

Leading scientists are advocating for annual prostate cancer screening for men with BRCA1 and BRCA2 gene mutations. Experts at the London-based Institute of Cancer Research (ICR) state that the ...

Former President Joe Biden is marking a milestone in his ongoing prostate cancer treatment. The 82-year-old Biden on Monday finished a round of radiation therapy to treat the aggressive form of cancer ...

OCEANSIDE, Calif. (FOX 5/KUSI) — The Oceanside Police Department’s Special Enforcement Section (SES) announced Monday the shutdown of two massage businesses in Oceanside after a year-long ...

A delayed inflation report on Friday is expected to deliver sobering data about the direction of U.S. prices, with economists forecasting that the Consumer Price Index in September rose at its fastest ...

BERLIN -- Combining enzalutamide (Xtandi) with androgen deprivation therapy (ADT) significantly improved overall survival (OS) in patients with prostate cancer at high risk for biochemical recurrence, ...

FISHERS, Ind. — A masseuse in Hamilton County is behind bars after he was accused of raping a customer at a Fishers business The investigation began on Monday when a woman told police she had been ...

Darolutamide, also known as Nubeqa and made by Bayer, is recommended in final draft guidance to treat adults with metastatic hormone-sensitive prostate cancer in combination with androgen deprivation ...